Key result
Four induced Pluripotent Stem Cell (iPSC) lines were successfully generated and characterized from patients with inherited dilated cardiomyopathy carrying distinct TTN truncating variants.
Why the study?
Heterogeneous clinical manifestations and variable therapy response present challenges in managing inherited dilated cardiomyopathy, prompting the need to deepen knowledge of TTN-associated disease.
The generation of these iPSC lines provides a patient-specific cellular model to study the mechanisms and potential therapies for inherited dilated cardiomyopathy caused by TTN truncating variants.
Answers are grounded in this paper and cite their sources.
These iPSC lines enable mechanistic studies of TTN cardiomyopathy; leaves open therapeutic translation pending validation.
Inherited dilated cardiomyopathy (iDCM) is a disease of the heart muscle, characterized by left ventricle enlargement, systolic dysfunction and arrhythmias. iDCM represents a common cause of heart failure and the most frequent cause of heart transplantation. Among the causative genes, TTN, encoding the sarcomeric protein Titin, represents the most prevalent (about 25 % of cases). The heterogeneous clinical manifestations and variable response to therapy represent a major challenge in patients' clinical management. To deepen the knowledge of this disease, we generated and fully characterized induced Pluripotent Stem Cell lines from 4 iDCM patients carrying 4 different truncating variants of TTN gene.
No takes yet. Share an insight, caveat, or question.
Thairi et al. (2025) studied Dilated Cardiomyopathy (n=4). iPSC reprogramming was evaluated on Generation and characterization of iPSC lines. Four induced Pluripotent Stem Cell (iPSC) lines were successfully generated and characterized from patients with inherited dilated cardiomyopathy carrying distinct TTN truncating variants.
Synapse has enriched 10 related papers. Consider them for comparative context: